Saniona Future Growth
Future criteria checks 2/6
Saniona is forecast to grow earnings and revenue by 40.2% and 35.3% per annum respectively.
Key information
40.2%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 35.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 56 | -42 | N/A | N/A | 1 |
| 12/31/2024 | 62 | -25 | N/A | N/A | 1 |
| 6/30/2024 | 25 | -82 | -76 | -76 | N/A |
| 3/31/2024 | 21 | -83 | -80 | -80 | N/A |
| 12/31/2023 | 17 | -96 | -86 | -86 | N/A |
| 9/30/2023 | 15 | -108 | -84 | -84 | N/A |
| 6/30/2023 | 12 | -33 | -101 | -100 | N/A |
| 3/31/2023 | 11 | -100 | -212 | -211 | N/A |
| 12/31/2022 | 15 | -212 | -283 | -282 | N/A |
| 9/30/2022 | 15 | -334 | -331 | -331 | N/A |
| 6/30/2022 | 15 | -445 | -383 | -382 | N/A |
| 3/31/2022 | 14 | -461 | -325 | -324 | N/A |
| 12/31/2021 | 10 | -411 | -347 | -345 | N/A |
| 9/30/2021 | 9 | -326 | -326 | -323 | N/A |
| 6/30/2021 | 9 | -280 | -296 | -291 | N/A |
| 3/31/2021 | 9 | -200 | -244 | -239 | N/A |
| 12/31/2020 | 8 | -73 | -179 | -174 | N/A |
| 9/30/2020 | 11 | -25 | -153 | -145 | N/A |
| 6/30/2020 | 9 | -5 | -124 | -119 | N/A |
| 3/31/2020 | 8 | -1 | -132 | -127 | N/A |
| 12/31/2019 | 7 | -69 | -102 | -99 | N/A |
| 9/30/2019 | 5 | -96 | -90 | -89 | N/A |
| 6/30/2019 | 49 | -53 | -42 | -42 | N/A |
| 3/31/2019 | 52 | -52 | -31 | -30 | N/A |
| 12/31/2018 | 55 | -41 | -24 | -23 | N/A |
| 9/30/2018 | 57 | -32 | -33 | -33 | N/A |
| 6/30/2018 | 17 | -61 | -72 | -71 | N/A |
| 3/31/2018 | 17 | -56 | N/A | -62 | N/A |
| 12/31/2017 | 21 | -49 | N/A | -57 | N/A |
| 9/30/2017 | 21 | -47 | N/A | -50 | N/A |
| 6/30/2017 | 68 | -6 | N/A | -3 | N/A |
| 3/31/2017 | 67 | -2 | N/A | -5 | N/A |
| 12/31/2016 | 75 | 2 | N/A | 8 | N/A |
| 9/30/2016 | 71 | 10 | N/A | 3 | N/A |
| 6/30/2016 | 23 | -25 | N/A | -32 | N/A |
| 3/31/2016 | 25 | -21 | N/A | -25 | N/A |
| 12/31/2015 | 14 | -23 | N/A | -29 | N/A |
| 9/30/2015 | 16 | -23 | N/A | -18 | N/A |
| 6/30/2015 | 19 | -16 | N/A | -15 | N/A |
| 3/31/2015 | 23 | -10 | N/A | -5 | N/A |
| 12/31/2014 | 22 | -6 | N/A | -8 | N/A |
| 12/31/2013 | 13 | -1 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 30S is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 30S is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 30S is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 30S's revenue (35.3% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: 30S's revenue (35.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 30S's Return on Equity is forecast to be high in 3 years time